Ziopharm Oncology (ZIOP) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q4 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.59 million.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Acme United (ACU) Misses Q1 EPS by 20c
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
